Evidence map›Paper›PMID 36131121›Full record

ArticleScientific reports2022

Publisher Correction: A lightweight neural network with multiscale feature enhancement for liver CT segmentation.

Mohammed Yusuf Ansari, Yin Yang, Shidin Balakrishnan, Julien Abinahed, Abdulla Al-Ansari, Mohamed Warfa, Omran Almokdad, Ali Barah, Ahmed Omer, Ajay Vikram Singh and 7 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Mohammed Yusuf AnsariHamad Medical Corporation, Doha, Qatar.
Yin YangHamad Bin Khalifa University, Doha, Qatar.
Shidin BalakrishnanHamad Medical Corporation, Doha, Qatar.
Julien AbinahedHamad Medical Corporation, Doha, Qatar.
Abdulla Al-AnsariHamad Medical Corporation, Doha, Qatar.
Mohamed WarfaWake Forest Baptist Medical Center, Winston-Salem, USA.
Omran AlmokdadHamad Medical Corporation, Doha, Qatar.
Ali BarahHamad Medical Corporation, Doha, Qatar.
Ahmed OmerHamad Medical Corporation, Doha, Qatar.
Ajay Vikram SinghGerman Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Pramod Kumar MeherC. V. Raman Global University, Bhubaneswar, India.
Jolly BhadraQatar University, Doha, Qatar.
Osama HalabiQatar University, Doha, Qatar.
Mohammad Farid AzampourTechnische Universität München, Munich, Germany.
Nassir NavabTechnische Universität München, Munich, Germany.
Thomas WendlerTechnische Universität München, Munich, Germany.
Sarada Prasad DakuaHamad Medical Corporation, Doha, Qatar. SDakua@hamad.qa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36131121
PMCPMC9492655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.